Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Proto-oncogene tyrosine-protein kinase Src' and Ligand = 'BDBM205331'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM205331 (US9249125, 84) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(n1)-c1ccc(=O)n(CCO)c1 Show InChI InChI=1S/C35H32N10O4/c1-21(2)29-16-32(45(43-29)24-8-12-34(47)44(19-24)13-14-46)41-35(48)40-28-10-11-30(26-6-4-3-5-25(26)28)49-33-17-31(36-20-37-33)39-23-7-9-27-22(15-23)18-38-42-27/h3-12,15-21,46H,13-14H2,1-2H3,(H,38,42)(H,36,37,39)(H2,40,41,48)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9249125 (2016) BindingDB Entry DOI: 10.7270/Q2CN72QG
					More data for this Ligand-Target Pair